Menu Close

BioCardia brings on clinical affairs VP to move regenerative heart therapy through phase 3

BioCardia has brought on Mark Schwartz to be its vice president of clinical affairs, as it moves forward with a phase 3 trial of its cell therapy treatment for heart failure following a heart attack. Schwartz has helped lead clinical study design and … (본문 전체 11/8/2018 1:33 AM)